Close

Form 6-K ASTRAZENECA PLC For: Nov 05

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/20/2024

1. NFLX
2. TSM
3. ISRG
4. TSLA
5. SPY
6. INFY
7. SNV
8. SMCI
9. SLB
10. PPG


November 5, 2014 6:43 AM EST



FORM 6-K


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


Report of Foreign Issuer


Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934

For the month of��November 2014

Commission File Number:��001-11960

AstraZeneca PLC

2 Kingdom Street, London W2 6BD

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F X �����������Form 40-F��__

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): �����������

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes��__�����������������No X

If Yes is marked, indicate below the file number assigned to the Registrant in connection with Rule 12g3-2(b):���82-_____________
�
�


�
AstraZeneca Third Quarter & Nine Months Results 2014
�
Tomorrow, Thursday, 6 November 2014, AstraZeneca will release third quarter and nine months results 2014 at 07:00 gmt.

An analysts presentation of the third quarter and nine months results will take place at 12:00 gmt and will be accessible by a choice of two routes:
1) Audio webcast available at http://www.astrazeneca.com/investors and http://info.astrazenecaevents.com . You will be able to email questions to the presenters during the Q&A session.

2) Teleconference with Q&A.
�
Dial in numbers:
UK (freephone):������������������������������������������� 0800 694 2370
International:������������������������������������������������ +44 1452 557749
Sweden (freephone):�������������������������������������0200 883 079
USA (freephone):�������������������������������������� �� 1 866 977 7645

Conference ID:�������������������������������������������� � 29619150#

Printable pdf versions of slides will be available to download on the AstraZeneca Investor Relations website ( http://www.astrazeneca.com/investors )15 minutes before the analysts presentation begins.

Details of the teleconference and webcast replay facilities are available on the Investor Relations section of the AstraZeneca website http://www.astrazeneca.com/investors and the AstraZeneca Events website: http://info.astrazenecaevents.com
.
�
�
�
�

��
�
SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AstraZeneca PLC




Date:�05 November�2014
By:��/s/ Adrian Kemp
�
Name: Adrian Kemp
�
Title: Company Secretary
�


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings